Literature DB >> 7071071

Saliva-plasma drug concentration ratios during absorption: theoretical considerations and pharmacokinetic implications.

J Posti.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 7071071

Source DB:  PubMed          Journal:  Pharm Acta Helv        ISSN： 0031-6865


× No keyword cloud information.
  8 in total

Review 1.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

2.  A comparison of serum and saliva paracetamol concentrations.

Authors:  M Smith; E Whitehead; G O'Sullivan; F Reynolds
Journal:  Br J Clin Pharmacol       Date:  1991-05       Impact factor: 4.335

3.  The effect of pirenzepine on gastric emptying and salivary flow rate: constraints on the use of saliva paracetamol concentrations for the determination of paracetamol pharmacokinetics.

Authors:  F Kamali; C Edwards; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

4.  Average parameters as a trend to reduce the residual variability in bioequivalence trials.

Authors:  P Fagiolino; M Vazquez
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Apr-Jun       Impact factor: 2.441

5.  Time-dependent variability of chloroquine secretion into human saliva.

Authors:  C O Onyeji; F A Ogunbona
Journal:  Pharm World Sci       Date:  1996-12

6.  Is saliva suitable as a biological fluid in relative bioavailability studies? Analysis of its performance in a 4 x 2 replicate crossover design.

Authors:  M Esperanza Ruiz; Pietro Fagiolino; Perla M de Buschiazzo; M Guillermina Volonté
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-06-30       Impact factor: 2.441

7.  Influence of local radiotherapy on penetration of fluconazole into human saliva.

Authors:  J Oliary; M Tod; K Louchahi; O Petitjean; B Frachet; V Le Gros; N Brion
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

8.  Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer.

Authors:  Therese Ericsson; Antje Blank; Cornelia von Hagens; Michael Ashton; Angela Äbelö
Journal:  Eur J Clin Pharmacol       Date:  2014-09-25       Impact factor: 2.953
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.